Skip to content
OpenCapital
Get started

Bio-Techne TECH Q2 2026 earnings

Reported February 4, 2026 · Before market open

Revenue$295.9MBeat by $5.4MDiluted EPS$0.46Beat by $0.03
Revenue estimate$290.5M
EPS estimate$0.43

Next report

Aug 5, 2026 (in a month)
Revenue estimate$314.4M
EPS estimate$0.53

Financials

Q2 2026

Income statement

See full
Revenue$295.9M-0.4%
Gross profit$191.3M-1.3%
Operating income$54.5M+14.9%
Net income$38.0M+8.9%
EPS (diluted)$0.24+9.1%

Balance sheet

See full
Cash & equivalents$172.9M-2.6%
Total debt$350.9M-11.2%
Total equity$2.0B-3.2%
Total assets$2.5B-5.5%

Cash flow

See full
Operating cash flow$82.4M-2.3%
CapEx$5.9M-13.2%
Free cash flow$76.5M-1.3%

Valuation & ratios

Q2 2026

Valuation

See full
Market cap$9.16B-19.9%
Enterprise value$9.34B-19.9%
P/S7.5×-2.0×

Profitability

See full
Gross margin65.2%-0.4pp
FCF margin18.3%-2.9pp

Returns & leverage

See full
Debt / equity0.2×0.0×
Current ratio4.5×+0.6×

Segments

By product

See full
Consumables$235.4M+2.0%
Instruments$29.6M-4.1%
Service$22.3M-18.4%
Royalty$8.5M+5.1%

By segment

See full
Protein Sciences$215.1M+1.7%
Diagnostics And Spatial Biology$81.2M-3.5%

Versus estimates

Revenue

Q3 2026$311.4MMiss by $4.7M
Q2 2026$295.9MBeat by $5.4M
Q1 2026$286.6MMiss by $4.8MQ4 2025$317.0MBeat by $22.3MQ3 2025$316.2MMiss by $9.3MQ2 2025$297.0MMiss by $20.5M

Diluted EPS

Q3 2026$0.53Miss by $0.02
Q2 2026$0.46Beat by $0.03
Q1 2026$0.42Miss by $0.00Q4 2025$0.53Beat by $0.03Q3 2025$0.56Beat by $0.05Q2 2025$0.42Beat by $0.03

Ask the moment Bio-Techne reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bio-Techne report Q2 2026 earnings?
Bio-Techne (TECH) reported Q2 2026 earnings on February 4, 2026 before market open.
What were Bio-Techne's Q2 2026 revenue and EPS?
Bio-Techne reported revenue of $295.9M and diluted EPS of $0.46 for Q2 2026.
Did Bio-Techne beat estimates in Q2 2026?
Revenue beat the consensus estimate of $290.5M by $5.4M. EPS beat the consensus estimate of $0.43 by $0.03.
How did Bio-Techne's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.4% from $297.0M a year earlier and diluted EPS grew 9.5% from $0.42.
Where can I find Bio-Techne's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-009994) and the 10-Q periodic report (0001104659-26-010335) directly on SEC EDGAR. The filing index links above go to sec.gov.